U.S. food regulators gather information on MDH and Everest spices following contamination allegations

The U.S. Food and Drug Administration (FDA) has released information on products from Indian spice makers MDH and Everest after Hong Kong suspended the sale of some products over suspected high levels of carcinogenic pesticides. are collecting.

“FDA is aware of the reports and is gathering additional information regarding the situation,” an FDA spokesperson said. Reuters.

Hong Kong this month suspended the sale of three MDH spice blends and one Everest spice mix for fish curry. Singapore has also ordered a recall of the Everest spice mix, saying it contains high levels of ethylene oxide, making it unfit for human consumption and posing a cancer risk if exposed for long periods of time.

MDH and Everest did not immediately respond. Reuters We request comments on this matter.

Everest has previously said the spice is safe to consume. MDH has so far not responded to inquiries about the product.

MDH Spice and Everest Spice are most popular in India and are also sold in Europe, Asia, and North America. India's food regulator, the Food Safety and Standards Authority of India (FSSAI), is currently checking the quality standards of both companies, following the moves by Hong Kong and Singapore.

The Spice Board, the Indian government's spice export regulator, on Wednesday sought data on MDH and Everest exports from authorities in Hong Kong and Singapore and is working with both companies to find the “root cause” of quality issues during inspections. It was announced that there was. It started with their factory.

In 2019, several batches of MDH's products were recalled in the United States due to Salmonella contamination.